Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CEL-SCI-CORPORATION-14518402/news/CEL-SCI-NEW-STORY-CEL-SCI-Reports-June-Patient-Enrollment-in-Its-Phase-3-Head-and-Neck-Cancer-Tria-20625129/?utm_source=whatsapp&utm_medium=social&utm_campaign=share